US health regulators make it easier to sell menopause tests
What happened
US health regulators just made it easier to bring a new type of menopause test to market. Companies that make these tests will now face fewer regulatory hurdles to sell them.
Why it matters
New medical devices often face a long, expensive approval process. This rule creates a specific, less burdensome pathway for a new category of menopause tests. This means more companies can develop and sell these tests, giving patients more options for diagnosis.
The signal
Watch for how many new menopause test systems appear on the market in the next 12-24 months, and how quickly they get approved.